Related references
Note: Only part of the references are listed.Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
M. J. M. Bonten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Randomized Clinical Trial of the Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine Compared to 23-Valent Polysaccharide Vaccine in Frail, Hospitalized Elderly
C. Raina MacIntyre et al.
PLOS ONE (2014)
Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older: Results of an Open-Label, Randomized, Controlled Trial
Ghassan Dbaibo et al.
DRUGS & AGING (2013)
Diagnostic accuracy of a serotype-specific antigen test in community-acquired pneumonia
Susanne M. Huijts et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees
Angelique P. A. Vermeiren et al.
JOURNAL OF CLINICAL VIROLOGY (2013)
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
Lisa A. Jackson et al.
VACCINE (2013)
Innate immunosenescence: Effect of aging on cells and receptors of the innate immune system in humans
Rafael Solana et al.
SEMINARS IN IMMUNOLOGY (2012)
Age effects on B cells and humoral immunity in humans
Daniela Frasca et al.
AGEING RESEARCH REVIEWS (2011)
The aging of the immune system
Daniela Weiskopf et al.
TRANSPLANT INTERNATIONAL (2009)
B-cell responses to vaccination at the extremes of age
Claire-Anne Siegrist et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults:: Conjugate vaccine elicits improved antibacterial immune responses and immunological memory
Andres de Roux et al.
CLINICAL INFECTIOUS DISEASES (2008)
Share Paper
